文献速递脑血管病神经重症与神经感染

大核心梗死取栓全麻与非全麻比较:SELECT2预设二次分析

General vs Nongeneral Anesthesia for Endovascular Thrombectomy in Patients With Large Core Strokes: A Prespecified Secondary Analysis of SELECT2 Trial.
PubMed 文献 · Neurology · 2025-06-26

该研究为SELECT2试验的预设二次分析,纳入178例大核心梗死并接受血管内取栓的患者,其中104例(58%)接受全麻。结果显示,全麻与非全麻在90天改良Rankin量表(mRS)分布、功能独立和独立行走等方面均无显著差异,且卒中严重程度、缺血核心体积和侧支循环状态未改变这一关联。全麻组收缩压变异度≥40 mmHg和术中最低收缩压<100 mmHg更常见,但未影响功能结局。

要点

  • 大核心梗死取栓患者中,全麻与非全麻的90天功能结局无显著差异。
  • 全麻组收缩压变异度更大、术中最低收缩压更低,但未改变功能结局关联。
  • 卒中严重程度、ASPECTS、核心体积和侧支循环未修饰麻醉方式与结局的关联。

核心结论

  • 在大核心梗死取栓患者中,全麻与非全麻的90天功能结局无显著差异。

研究设计与样本

  • SELECT2试验的预设二次分析,纳入178例接受血管内取栓的大核心梗死患者,其中104例(58%)接受全麻。

主要发现

  • 全麻组与非全麻组mRS分布无差异(调整广义比值比1.21,95%CI 0.86-1.70)。
  • 功能独立(mRS 0-2)率全麻22% vs 非全麻18%(aRR 1.32,95%CI 0.75-2.35)。
  • 独立行走(mRS 0-3)率全麻41% vs 非全麻34%(aRR 1.22,95%CI 0.86-1.74)。
  • 成功再灌注(mTICI 2b-3)率全麻78% vs 非全麻84%(aRR 0.91,95%CI 0.79-1.06)。
  • 全麻组收缩压变异度≥40 mmHg和术中最低收缩压<100 mmHg更常见,但未修饰功能结局关联(交互p值分别为0.77和0.89)。

关键数值与推荐

  • 大核心梗死定义:平扫CT ASPECTS 3-5,或CT灌注/MRI核心体积≥50 mL,或两者兼有。
  • 主要结局为90天mRS分布,次要结局包括功能独立(mRS 0-2)、独立行走(mRS 0-3)、完全依赖或死亡(mRS 5-6)和死亡率。
  • 卒中严重程度、ASPECTS、缺血核心体积或侧支循环均未修饰麻醉方式与功能结局的关联(交互p值均>0.05)。

临床怎么用

  • 对于大核心梗死取栓患者,麻醉方式选择可根据机构协议和患者情况个体化,全麻与非全麻均可接受。
  • 全麻时需注意收缩压变异度和术中低血压的发生,但本研究未显示其影响功能结局。

局限性

  • 麻醉方式分配为非随机化,可能存在残余混杂。
  • 样本量有限,部分亚组分析效能不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The association of anesthesia approach during endovascular thrombectomy (EVT) with clinical outcomes in large strokes is unexplored. We aimed to evaluate whether general anesthesia (GA), compared with non-GA, was associated with better functional outcomes in the SELECT2 trial. METHODS: In a prespecified secondary analysis of the SELECT2 trial that enrolled patients with large strokes on noncontrast CT (Alberta Stroke Program Early CT Score [ASPECTS] 3-5), CT perfusion/MRI (core volume ≥50 mL), or both, functional outcomes were compared in EVT-treated patients who received GA or non-GA and whether this association was modified by stroke severity (NIH Stroke Scale score), ischemic injury estimates, and collateral status was evaluated. The primary outcome was 90-day functional status (ordinal modified Rankin Scale [mRS]). Secondary outcomes were functional independence (mRS scores 0-2), independent ambulation (mRS scores 0-3), complete dependence or death (mRS scores 5-6), and mortality. RESULTS: Of 178 EVT patients (median [interquartile range] age 66 [58-75] years, stroke severity 19 [15-23], CT-ASPECTS 4 [3-5], and core volume 101.5 [70-138] mL, 71 women [39.9%]), 104 (58%) received GA. Time from randomization to arterial puncture was longer with GA (40 [23-59] minutes) vs non-GA (27 [18-47] minutes), but procedural duration (GA: 57 [31.5-77] minutes vs non-GA: 49.5 [30-71] minutes) was similar. Successful reperfusion (modified treatment in cerebral infarction [mTICI] score 2b-3) rates were similar (GA 81 (78%) vs non-GA 62 (84%), adjusted relative risk [aRR] 0.91, 95% CI 0.79-1.06). In addition, mRS distribution did not differ between GA and non-GA groups (adjusted generalized odds ratio 1.21, 95% CI 0.86-1.70), as well as independent ambulation (GA: 41% vs non-GA: 34%, aRR 1.22, 95% CI 0.86-1.74) and functional independence (GA: 22% vs non-GA: 18%, aRR 1.32, 95% CI 0.75-2.35). Stroke severity, ASPECTS, ischemic core volume, or collaterals did not modify the association between anesthesia and functional outcome (all p-interaction >0.05). Patients experienced systolic blood pressure (SBP) variability ≥40 mm Hg and minimum intraprocedural SBP (<100 mm Hg) more frequently with GA, but this did not modify GA association with functional outcomes (p-interaction = 0.77 and 0.89, respectively). DISCUSSION: In patients with large core strokes randomized in SELECT2, EVT outcomes did not differ significantly based on anesthesia approach (GA or non-GA) without heterogeneity across stroke severity and size. While GA was associated with higher SBP variability and lower minimum SBP, this did not modify GA association with functional outcomes. While allocation to anesthesia approach was nonrandomized, our findings suggest that optimizing institutional protocols for preferred anesthesia technique, whether GA or non-GA, may enhance EVT procedural outcomes. TRIAL REGISTRATION INFORMATION: ClinicalTrials.gov ID: NCT03876457. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that in patients presenting within 24 hours with large vessel occlusion strokes undergoing EVT, the 90-day mRS score is comparable in those with or without GA.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Sarraj A, Blackburn S, Abraham MG, et al. General vs Nongeneral Anesthesia for Endovascular Thrombectomy in Patients With Large Core Strokes: A Prespecified Secondary Analysis of SELECT2 Trial. Neurology. 2025. PMID: 40570276. doi:10.1212/WNL.0000000000213819

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。